Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Central Admixture Pharmacy Services, Inc.
483
•Central Admixture Pharmacy Services, Inc.•August 25, 2023

Central Admixture Pharmacy Services, Inc. – FDA 483, Aug 25, 2023

Record Details

The FDA Form 483 inspection identified numerous deficiencies at the facility producing sterile parenteral and injection drug products. The Quality Control Unit's responsibilities and procedures were not in writing or fully followed, failing to ensure drug product quality, strength, identity, and purity. The Quality Unit failed to reject lots not meeting batch yield specifications after visual and AQL inspection (SOP-CAPS-4000688) and did not complete requalification for 31 critical API suppliers (SOP-CAPS-4000343). The firm repeatedly violated its Quality System procedure (SOP-CAPS-4000693, section 6.1) for notifying quality events.

The Quality Unit lacked comprehensive procedures for quality review of audit trails and electronic data, and procedures for maintaining production and control records. It failed to investigate and determine batch release, thoroughly investigate microbiological contamination in critical ISO 5 areas, and conduct timely investigations for customer complaints like a "cloudy syringe" in epidural injections. The Quality Unit also failed to investigate particulate matter in 250 mL bag container-closures and identify deficiencies in the 100% visual inspection process.

The firm lacked adequate written procedures for production and process controls to assure drug product identity, strength, purity, and quality. ISO 5 aseptic operators demonstrated inadequate aseptic technique. Customer complaints involving adverse patient drug experiences were not thoroughly investigated. A method transfer of the

Company
Central Admixture Pharmacy Services, Inc.
Inspection date
August 25, 2023
Product type
Drugs
Office
Los Angeles District Office
People
  • Jolanna A. Norton (Investigator)
  • Rachel C. Stanton
  • Joseph N. Oberholtzer
  • Xiaohui Shen
  • Dorit B Singh
View Company Profile

ID · 54d5108c-7600-42cc-b457-ef72ce742f71

Violation Codes2
21 CFR 21021 CFR 211

Full citation text and observation details available on the Dashboard.

Other documents for Central Admixture Pharmacy Services, Inc.
  • 483 - 2021-05-24May 24, 2021
  • 483 - 2018-09-11September 11, 2018
  • 483 - 2016-01-21January 21, 2016
  • 483 - 2014-08-08August 8, 2014

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Central Admixture Pharmacy Services, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.